Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study
Titel:
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study
Auteur:
Windecker, Stephan Tijssen, Jan Giustino, Gennaro GuimarĂ£es, Ana H.C. Mehran, Roxana Valgimigli, Marco Vranckx, Pascal Welsh, Robert C. Baber, Usman van Es, Gerrit-Anne Wildgoose, Peter Volkl, Albert A. Zazula, Ana Thomitzek, Karen Hemmrich, Melanie Dangas, George D.